Polydatin Protecting Kidneys against Hemorrhagic Shock-Induced Mitochondrial Dysfunction via SIRT1 Activation and p53 Deacetylation

被引:61
|
作者
Zeng, Zhenhua [1 ,2 ]
Chen, Zhongqing [1 ]
Xu, Siqi [2 ]
Zhang, Qin [1 ]
Wang, Xingmin [2 ]
Gao, Youguang [1 ,3 ]
Zhao, Ke-seng [2 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Crit Care Med, Guangzhou 510515, Guangdong, Peoples R China
[2] Southern Med Univ, Dept Pathophysiol, Guangdong Key Lab Shock & Microcirculat Res, Guangzhou 510515, Guangdong, Peoples R China
[3] Fujian Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Fuzhou 350005, Fujian, Peoples R China
关键词
PROXIMAL TUBULAR CELLS; ISCHEMIA-REPERFUSION; INJURY; RESVERATROL; EXPRESSION; POLYPHENOL; SIRTUINS; SURVIVAL; PROTEIN; MODEL;
D O I
10.1155/2016/1737185
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objectives. To ascertain if mitochondrial dysfunction (MD) of kidney cells is present in severe hemorrhagic shock and to investigate whether polydatin (PD) can attenuate MD and its protective mechanisms. Research Design and Methods. Renal tubular epithelial cells (RTECs) from rat kidneys experiencing HS and a cell line (HK-2) under hypoxia/reoxygenation (H/R) treatment were used. Morphology and function of mitochondria in isolated RTECs or culturedHK-2 cellswere evaluated, accompanied bymitochondrial apoptosis pathway-related proteins. Result. Severe MD was found in rat kidneys, especially in RTECs, as evidenced by swollen mitochondria and poorly defined cristae, decreased mitochondrial membrane potential (Delta Psi m), and reduced ATP content. PD treatment attenuated MD partially and inhibited expression of proapoptotic proteins. PD treatment increased SIRT1 activity and decreased acetylated-p53 levels. Beneficial effect of PD was abolished partially when the SIRT1 inhibitor Ex527 was added. Similar phenomena were shown in the H/R cell model; when pifithrin-alpha (p53 inhibitor) was added to the PD/Ex527 group, considerable therapeutic effects were regained compared with the PD group apart from increased SIRT1 activity. Conclusions. MD is present in severe HS, and PD can attenuate MD of RTECs via the SIRT1-p53 pathway. PDmight be a promising therapeutic drug for acute renal injury.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Capsaicin Protects Cardiomyocytes against Anoxia/Reoxygenation Injury via Preventing Mitochondrial Dysfunction Mediated by SIRT1
    He, Huan
    Zhou, Yue
    Huang, Jiyi
    Wu, Zelong
    Liao, Zhangping
    Liu, Dan
    Yin, Dong
    He, Ming
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [42] Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs
    Giulia Dell’Omo
    Daniela Crescenti
    Cristina Vantaggiato
    Chiara Parravicini
    Aurora Paola Borroni
    Nicoletta Rizzi
    Mariangela Garofalo
    Andrea Pinto
    Camilla Recordati
    Eugenio Scanziani
    Fabio Domenico Bassi
    Giancarlo Pruneri
    Paola Conti
    Ivano Eberini
    Adriana Maggi
    Paolo Ciana
    British Journal of Cancer, 2019, 120 : 537 - 546
  • [43] A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
    Zhang, Qi
    Zeng, Shelya X.
    Zhang, Yu
    Zhang, Yiwei
    Ding, Derong
    Ye, Qizhuang
    Meroueh, Samy O.
    Lu, Hua
    EMBO MOLECULAR MEDICINE, 2012, 4 (04) : 298 - 312
  • [44] Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
    Li, Ling
    Wang, Lisheng
    Li, Liang
    Wang, Zhiqiang
    Ho, Yinwei
    McDonald, Tinisha
    Holyoake, Tessa L.
    Chen, WenYong
    Bhatia, Ravi
    CANCER CELL, 2012, 21 (02) : 266 - 281
  • [45] Inhibitory effect of diacerein on diclofenac-induced acute nephrotoxicity in rats via modulating SIRT1/HIF-1α/NF-κB and SIRT1/p53 regulatory axes
    Mansoure, Abduallah Nasser
    Elshal, Mahmoud
    Helal, Manar G.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 131
  • [46] Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53
    Tang, Yuan-juan
    Zhang, Zhen
    Yan, Tong
    Chen, Ken
    Xu, Guo-fan
    Xiong, Shi-qiang
    Wu, Dai-qian
    Chen, Jie
    Jose, Pedro A.
    Zeng, Chun-yu
    Fu, Jin-juan
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [47] Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity
    Cui, Lan
    Guo, Jiabin
    Zhang, Qiang
    Yin, Jian
    Li, Jin
    Zhou, Wei
    Zhang, Tingfen
    Yuan, Haitao
    Zhao, Jun
    Zhang, Li
    Carmichael, Paul L.
    Peng, Shuangqing
    TOXICOLOGY LETTERS, 2017, 275 : 28 - 38
  • [48] CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1
    Yuan, Yu -Pei
    Ma, Zhen-Guo
    Zhang, Xin
    Xu, Si-Chi
    Zeng, Xiao-Feng
    Yang, Zheng
    Deng, Wei
    Tang, Qi-Zhu
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 114 : 38 - 47
  • [49] Secreted Klotho Protects Against Aging-associated Coronary Endothelial Dysfunction via SIRT1 Activation
    Chen, Kai
    Sun, Zhongjie
    FASEB JOURNAL, 2019, 33
  • [50] MiR-34a targets SIRT1 to reduce p53 deacetylation and promote sevoflurane inhalation anesthesia-induced neuronal autophagy and apoptosis in neonatal mice
    Xu, Xiang
    Li, Caifeng
    Zou, Junping
    Liu, Liang
    EXPERIMENTAL NEUROLOGY, 2023, 368